Article thumbnail
Location of Repository

Diagnostic and prognostic implications of the unfolding molecular biology of bone and soft tissue tumours.

By J F Graadt van Roggen, J V Bovée, J Morreau and P C Hogendoorn

Abstract

Sarcomas account for approximately 1-2% of human malignant disease and are relatively uncommon. Histopathological study of these mesenchymal tumours at light microscopic and ultrastructural level may not always provide an unambiguous diagnosis. It has become apparent with the identification of increasing numbers of tumour specific genetic alterations that (cyto) genetic evaluation could become a very helpful adjunct to histopathological assessment in reaching a correct diagnosis. Thus, once the different tumour types can be accurately identified and classified, more meaningful clinical trials can be initiated to evaluate and select optimal methods of management. In addition, an increasing awareness and understanding of the molecular changes associated with, and the genetic variability in, the various tumour groups is beginning to provide important new information about clinical progression and prognosis

Topics: Research Article
Year: 1999
DOI identifier: 10.1136/jcp.52.7.481
OAI identifier: oai:pubmedcentral.nih.gov:501486
Provided by: PubMed Central
Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.